Skip to content

A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01886690
Enrollment
148
Registered
2013-06-26
Start date
2013-08-20
Completion date
2014-08-18
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilateral LASIK Surgery

Brief summary

This study will compare the safety and efficacy of a new eye drop formulation with REFRESH PLUS® in participants following LASIK surgery.

Interventions

DRUGcarboxymethylcellulose sodium based new eye drop formulation

1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation in each eye as per protocol for 90 days.

1 to 2 drops carboxymethylcellulose sodium based (REFRESH PLUS®) eye drops in each eye as per protocol for 90 days.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

-Patients scheduled for LASIK surgery in both eyes.

Exclusion criteria

* Any systemic medication use within 3 months of screening (including over the counter, herbal, prescription, or nutritional supplement) which may affect dry eye or vision * Use of topical eye medication other than prescribed for use in pre- or post-operative care * Use of RESTASIS® or other topical ophthalmic cyclosporine product within 6 months prior to Screening * Eye infection, inflammation, or allergy * Soft contact lenses in the previous 7 days or rigid contact lenses in the previous 30 days prior to LASIK surgery.

Design outcomes

Primary

MeasureTime frameDescription
Ocular Surface Disease Index© (OSDI) Score Using a 5-Point ScaleDay 90The OSDI© is a 12-question survey for patients to document their dry eye disease symptoms. Each question is rated on a 5-point scale (0=none of the time and 4 = all of the time). The scores are totaled over the 12 questions and normalized/converted to a score of 0-100 (0=no disability and 100=complete disability).

Secondary

MeasureTime frameDescription
Change From Baseline in Corneal Staining in the Worse EyeBaseline, Day 90The cornea is the transparent front part of the eye which covers the iris and pupil. Corneal staining in the worse eye following administration of fluorescein dye in the eye is graded using a 6-point scale (0=no staining, 5=severe staining) over 5 areas of the clear central part of the eye for a minimum score of 0 and maximum score of 25. The higher the grade score, the worse the dry eye condition. A negative change from baseline represents a decrease in corneal staining (improvement) and a positive change from baseline represents an increase in corneal staining (worsening).
Change From Baseline in Tear Break-up Time (TBUT) in the Worse EyeBaseline, Day 90TBUT is the time required for dry spots to appear on the surface of the eye after blinking in the worse eye. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film. A positive number change from baseline indicates an increase in TBUT (improvement) and a negative number change from baseline indicates a decrease in TBUT (worsening).
Change From Baseline in the Schirmer Test in the Worse EyeBaseline, Day 90The Schirmer's Test measures the rate of the secretion of tears produced by the eye over 5 minutes in the worse eye. The results indicate the presence of dry eye (Normal = greater than or equal to 10 millimeters (mm) of tears, Dry Eye = less than 10 mm of tears). The smaller the number, the more severe the dry eye. A positive number change from baseline indicates an increase in tears (improvement) and a negative number change from baseline indicates a decrease in tears (worsening).
Change From Baseline in Uncorrected Visual Acuity in the Worse EyeBaseline, Day 90Uncorrected visual acuity in the worse eye is measured using an eye chart and is reported as the number of letters read correctly (ranging from 0 to 100 letters) without corrective lenses. The lower the number of letters read correctly on the eye chart, the worse the vision (or visual acuity). A positive number change from baseline in the number of letters read correctly indicates an improvement and a negative number change from baseline indicates a worsening.

Countries

Australia, Canada

Participant flow

Participants by arm

ArmCount
New Eye Drop Formulation
1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation in each eye as per protocol for 90 days.
75
REFRESH PLUS®
1 to 2 drops carboxymethylcellulose sodium based (REFRESH PLUS®) eye drops in each eye as per protocol for 90 days.
73
Total148

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPersonal Reasons01
Overall StudyProtocol Violation01

Baseline characteristics

CharacteristicNew Eye Drop FormulationREFRESH PLUS®Total
Age, Customized
< 40 years
58 Participants51 Participants109 Participants
Age, Customized
≥ 40 years
17 Participants22 Participants39 Participants
Sex: Female, Male
Female
36 Participants39 Participants75 Participants
Sex: Female, Male
Male
39 Participants34 Participants73 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
4 / 7518 / 73
serious
Total, serious adverse events
0 / 751 / 73

Outcome results

Primary

Ocular Surface Disease Index© (OSDI) Score Using a 5-Point Scale

The OSDI© is a 12-question survey for patients to document their dry eye disease symptoms. Each question is rated on a 5-point scale (0=none of the time and 4 = all of the time). The scores are totaled over the 12 questions and normalized/converted to a score of 0-100 (0=no disability and 100=complete disability).

Time frame: Day 90

Population: Per Protocol: all randomized patients who had no significant protocol violations

ArmMeasureValue (MEAN)Dispersion
New Eye Drop FormulationOcular Surface Disease Index© (OSDI) Score Using a 5-Point Scale6.99 Scores on a ScaleStandard Deviation 8.511
REFRESH PLUS®Ocular Surface Disease Index© (OSDI) Score Using a 5-Point Scale6.63 Scores on a ScaleStandard Deviation 7.071
Secondary

Change From Baseline in Corneal Staining in the Worse Eye

The cornea is the transparent front part of the eye which covers the iris and pupil. Corneal staining in the worse eye following administration of fluorescein dye in the eye is graded using a 6-point scale (0=no staining, 5=severe staining) over 5 areas of the clear central part of the eye for a minimum score of 0 and maximum score of 25. The higher the grade score, the worse the dry eye condition. A negative change from baseline represents a decrease in corneal staining (improvement) and a positive change from baseline represents an increase in corneal staining (worsening).

Time frame: Baseline, Day 90

Population: Per Protocol: all randomized patients who had no significant protocol violations and who had data at the noted time point

ArmMeasureGroupValue (MEAN)Dispersion
New Eye Drop FormulationChange From Baseline in Corneal Staining in the Worse EyeBaseline0.9 Scores on a ScaleStandard Deviation 1.28
New Eye Drop FormulationChange From Baseline in Corneal Staining in the Worse EyeChange from Baseline at Day 90 (N=68, 57)0.2 Scores on a ScaleStandard Deviation 1.96
REFRESH PLUS®Change From Baseline in Corneal Staining in the Worse EyeBaseline1.2 Scores on a ScaleStandard Deviation 1.31
REFRESH PLUS®Change From Baseline in Corneal Staining in the Worse EyeChange from Baseline at Day 90 (N=68, 57)-0.3 Scores on a ScaleStandard Deviation 1.61
Secondary

Change From Baseline in Tear Break-up Time (TBUT) in the Worse Eye

TBUT is the time required for dry spots to appear on the surface of the eye after blinking in the worse eye. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film. A positive number change from baseline indicates an increase in TBUT (improvement) and a negative number change from baseline indicates a decrease in TBUT (worsening).

Time frame: Baseline, Day 90

Population: Intent-to-Treat: all randomized patients who had data at the noted time point

ArmMeasureGroupValue (MEAN)Dispersion
New Eye Drop FormulationChange From Baseline in Tear Break-up Time (TBUT) in the Worse EyeBaseline11.88 SecondsStandard Deviation 11.656
New Eye Drop FormulationChange From Baseline in Tear Break-up Time (TBUT) in the Worse EyeChange from Baseline at Day 90 (N=75, 71)1.21 SecondsStandard Deviation 9.299
REFRESH PLUS®Change From Baseline in Tear Break-up Time (TBUT) in the Worse EyeBaseline9.27 SecondsStandard Deviation 5.121
REFRESH PLUS®Change From Baseline in Tear Break-up Time (TBUT) in the Worse EyeChange from Baseline at Day 90 (N=75, 71)1.08 SecondsStandard Deviation 5.304
Secondary

Change From Baseline in the Schirmer Test in the Worse Eye

The Schirmer's Test measures the rate of the secretion of tears produced by the eye over 5 minutes in the worse eye. The results indicate the presence of dry eye (Normal = greater than or equal to 10 millimeters (mm) of tears, Dry Eye = less than 10 mm of tears). The smaller the number, the more severe the dry eye. A positive number change from baseline indicates an increase in tears (improvement) and a negative number change from baseline indicates a decrease in tears (worsening).

Time frame: Baseline, Day 90

Population: Intent-to-Treat: all randomized patients who had data at the noted time point

ArmMeasureGroupValue (MEAN)Dispersion
New Eye Drop FormulationChange From Baseline in the Schirmer Test in the Worse EyeBaseline13.1 Millimeters in 5 minutes (mm/5 min)Standard Deviation 9.1
New Eye Drop FormulationChange From Baseline in the Schirmer Test in the Worse EyeChange from Baseline at Day 90 (N=75, 71)1.4 Millimeters in 5 minutes (mm/5 min)Standard Deviation 8.55
REFRESH PLUS®Change From Baseline in the Schirmer Test in the Worse EyeBaseline13.0 Millimeters in 5 minutes (mm/5 min)Standard Deviation 8.74
REFRESH PLUS®Change From Baseline in the Schirmer Test in the Worse EyeChange from Baseline at Day 90 (N=75, 71)1.3 Millimeters in 5 minutes (mm/5 min)Standard Deviation 9.89
Secondary

Change From Baseline in Uncorrected Visual Acuity in the Worse Eye

Uncorrected visual acuity in the worse eye is measured using an eye chart and is reported as the number of letters read correctly (ranging from 0 to 100 letters) without corrective lenses. The lower the number of letters read correctly on the eye chart, the worse the vision (or visual acuity). A positive number change from baseline in the number of letters read correctly indicates an improvement and a negative number change from baseline indicates a worsening.

Time frame: Baseline, Day 90

Population: Per Protocol: all randomized patients who had no significant protocol violations and who had data at the noted time point

ArmMeasureGroupValue (MEAN)Dispersion
New Eye Drop FormulationChange From Baseline in Uncorrected Visual Acuity in the Worse EyeBaseline51.1 Letters Read CorrectlyStandard Deviation 10
New Eye Drop FormulationChange From Baseline in Uncorrected Visual Acuity in the Worse EyeChange from Baseline at Day 90 (N=68, 57)5.8 Letters Read CorrectlyStandard Deviation 5.24
REFRESH PLUS®Change From Baseline in Uncorrected Visual Acuity in the Worse EyeBaseline53.1 Letters Read CorrectlyStandard Deviation 9.49
REFRESH PLUS®Change From Baseline in Uncorrected Visual Acuity in the Worse EyeChange from Baseline at Day 90 (N=68, 57)4.7 Letters Read CorrectlyStandard Deviation 6.02

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026